Feb 02, 2021 (IAM Newswire via COMTEX) -- We're in for another busy IPO week with nine companies aiming to raise $2.7 billion.
Canadian digital service provider Telus Corporation /zigman2/quotes/205315185/composite TU +0.88% will attempt to woo investors for its public offering of subsidiary Telus International /zigman2/quotes/224262532/composite TIXT +2.81% , planning to raise $800 million at a $6.4 billion market cap. The fast growing and profitable Telus International companies have about 600 clients, including Uber Technologies /zigman2/quotes/211348248/composite UBER +0.81% , TikTok, PayPal /zigman2/quotes/208054269/composite PYPL +0.53% , MasterCard /zigman2/quotes/207581792/composite MA -0.02% , Wix Fitbit, TransUnion /zigman2/quotes/209192458/composite TRU +1.08% and even the retail giant Zara.
German specialty chemical producer offering electroplating solutions, Atotech (ATC) plans to raise $700 million at a $3.8 billion market cap. Although IPO proceeds will be used to pay off debt, it will be leveraged post its IPO. But it has resilient margins and strong cash flow generation.
Virtual B2B and B2C communication platform ON24 /zigman2/quotes/224262505/composite ONTF +1.13% plans to raise $409 million at a $2.6 billion market cap. The company benefited as customers are increasingly choosing experience over product and priceby creating webinars, virtual events, and content experiences for customer and business engagement. COVID-19 might have shattered the physical event industry, but it created the era of digital events and ON24 is well positioned to benefit from it.
Pre-clinical stage biotech company Sana Biotechnology /zigman2/quotes/224369191/composite SANA +9.13% has filed to raise $323 million in its IPO. Its ambitious pipeline of treatment candidates useits cell engineering technologiesand are aimed at treating a range of diseases including cancer, diabetes, and CNS disorders.
Following its IPO attempt in 2015, the non-bank lender IoanDepot /zigman2/quotes/201869143/composite LDI -12.17% plans to raise $300 million at a $6.5 billion market cap. With a focus on mortgage and unsecured personal loans, it is fast growing and profitable with revenue tripling during the first nine months of 2020.
Phase 2 biotech developing oral small molecule therapies for autoimmune disease with the help of AI, Landos Biopharma /zigman2/quotes/224337277/composite LABP -3.42% is gunning to raise $100 million at $650 million market cap.
A provider of engineering and design services for the integration of environmental equipment systems in indoor facilities, Urban-gro Inc /zigman2/quotes/213600644/composite UGRO +1.13% plans to raise $45 million at a $97 million market cap as it enters the NASDAQ playfield, under the same ticker.
The organic Chinese fertilizer producer Muliang Viagoo Technology /zigman2/quotes/202161263/delayed MULG -6.67% aims to raise $40 million at a $194 million market cap. Although it is profitable, it did see its revenue decline during the first nine months of 2020.
Danish Phase 1/2 AI biotech Evaxion Biotech /zigman2/quotes/224262462/composite EVAX +0.76% is pursuing a $30 million IPO at a $233 million market cap, attracting investors with its potential to develop novel immunotherapies to treat several types of cancer, along with bacterial diseases and viral infections.
Who would have thought that a year with an unprecedented health crisis that caused the economy to plummet would also be the strongest IPO year in decades? Yet, it happened and by the looks of it, the positive IPO momentum is set to stay in 2021.
This article is not a press release and is contributed by a verified independent journalist for IAMNewswire. It should not be construed as investment advice at any time please read the full disclosure . IAM Newswire does not hold any position in the mentioned companies. Press Releases – If you are looking for full Press release distribution contact: firstname.lastname@example.org Contributors – IAM Newswire accepts pitches. If you're interested in becoming an IAM journalist contact: email@example.com
Is there a problem with this press release? Contact the source provider Comtex at firstname.lastname@example.org. You can also contact MarketWatch Customer Service via our Customer Center.